Dicerna Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €141.56M +587.4% -€97.14M -6.4% -68.6% +4.4 pp €160.99M +3,203.1% 113.7% +0.90 pp
    €20.59M +287.0% -€103.78M +35.6% -503.9% +9.3 pp €4.87M -69.7% 23.7% -2.8 pp
    €5.32M +171.2% -€76.55M +48.0% -1,438.7% +12 pp €16.07M -141.3% 302.1% +23 pp
    €1.96M +671.9% -€51.73M +0.9% -2,637.2% +180 pp -€38.94M -6.4% -1,984.8% +140 pp
    €254.16K +60.3% -€51.27M -5.3% -20,173.9% +140 pp -€41.61M +1.3% -16,372.2% +95 pp
    €158.53K +∞% -€54.14M +31.1% -34,151.6% -340 pp -€41.07M +45.5% -25,904.9% -260 pp
    €0.00 +NaN% -€41.30M +158.9% N/A -€28.22M +211.0% N/A
    €0.00 -100.0% -€15.95M +83.0% N/A -€9.07M -32.6% N/A
    €6.04M -11.3% -€8.72M +18.3% -144.3% -0.36 pp -€13.45M +86.7% -222.6% -1.2 pp
    €6.81M -€7.37M -108.2% -€7.21M -105.8%

    Notifications